HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy
30 August 2024 (11:00 - 11:12)
Organised by: 
About the speaker
University College London, London (United Kingdom of Great Britain & Northern Ireland)
8 More presentations in this session
Access the full session
The Event
ESC Congress 2024
30 August 2024
11:00 CET
You may be interested in
Congress Presentation
Congress Session
